EmployblEmploybl logo
employbl
Shinobi Therapeutics logo

Shinobi Therapeutics Funding & Investors

South San Francisco, CA

Shinobi Therapeutics focuses on creating hypoimmune CD8Ξ±Ξ² iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therapies. Shinobi's innovative approach aims to reduce costs and improve patient outcomes through durable responses and redosing capabilities.

shinobitx.com

Total Amount Raised: $178,000,000

Shinobi Therapeutics Funding Rounds

  • Grant

    $59,000,000

    Grant Investors

    AMED

  • Series A

    $68,000,000

    Series A Investors

    Mitsubishi UFJ Capital
    Yosemite

  • Series A

    $51,000,000

    Series A Investors

    Eight Roads Ventures Japan
    LSP
    F-Prime
    JIC Venture Growth Investments
    D3
    Astellas Venture Management
    Fast Track Initiative
Funding info provided by Diffbot.